Health Advances AACC Reception and Panel

What Do the Next 10 Years Hold for CRISPR?

Digital Biomarkers – The Future of Precision Medicine

Impact of Innovation on Market Access for Wound Care Products

Demystifying SARS-CoV-2 Testing for COVID-19 (Fourth Edition – The Long-Term Dx Industry Impact)

Xenotransplantation: Market Disrupter or Expander?

From Treating Cancer to Curing Cancer – The Promise of mRNA Vaccines in Oncology

ASCO 2022: Striving to Ensure No Patient is Left Behind

Digital Health in Japan and Korea – Where Is It Heading?

Opportunities and Challenges for Drug Makers in MDD

Rise of Innovative Medtech in APAC

AAOS 2022: The Latest Ortho Insights

Strategies to Overcome Challenges in Commercializing Treatments for Rare Diseases

Women’s Health at Home: Reflections on a Rapidly Growing Space

Building and Defending Markets; Reflections on Attending DTx and NASS Conferences

Resurgence in Drug Development for Renal Diseases

AI in Healthcare: Insights from Two Decades of FDA Approvals

Evidence Generation Strategy under Germany’s Digital Healthcare: Is More Better?

India, the Generic Manufacturing Powerhouse, Biosimilar Next?

Tencent-Backed Wedoctor Is Going Public: What Are the Next Steps for Chinese Digital Health Companies?

Health Advances Blog

Author: healthadvances

Health Advances AACC Reception and Panel

What Do the Next 10 Years Hold for CRISPR?

Digital Biomarkers – The Future of Precision Medicine

Impact of Innovation on Market Access for Wound Care Products

Demystifying SARS-CoV-2 Testing for COVID-19 (Fourth Edition – The Long-Term Dx Industry Impact)

Xenotransplantation: Market Disrupter or Expander?

From Treating Cancer to Curing Cancer – The Promise of mRNA Vaccines in Oncology

ASCO 2022: Striving to Ensure No Patient is Left Behind

Digital Health in Japan and Korea – Where Is It Heading?

Opportunities and Challenges for Drug Makers in MDD

Rise of Innovative Medtech in APAC

AAOS 2022: The Latest Ortho Insights

Strategies to Overcome Challenges in Commercializing Treatments for Rare Diseases

Women’s Health at Home: Reflections on a Rapidly Growing Space

Building and Defending Markets; Reflections on Attending DTx and NASS Conferences

Resurgence in Drug Development for Renal Diseases

AI in Healthcare: Insights from Two Decades of FDA Approvals

Evidence Generation Strategy under Germany’s Digital Healthcare: Is More Better?

India, the Generic Manufacturing Powerhouse, Biosimilar Next?

Tencent-Backed Wedoctor Is Going Public: What Are the Next Steps for Chinese Digital Health Companies?